Discover

AMLX
Amylyx Pharmaceuticals, Inc.
23.63
1 x 23.16
1 x 24.10
bid
ask
+
0.96
4.23%
6602 @ 04:00 PM
23.63 +0.00 (0.00%)
Ytd95.61%
1y202.17%
22.19
day range
23.73
7.63
52 week range
24.60
Open22.72Prev Close22.67Low22.19High23.73Mkt Cap2.63B
Vol0.00Avg Vol1.66MEPS-1.50P/E-15.75Forward P/E-16.47
Beta-0.20Short Ratio6.93Inst. Own105.86%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg17.43200-d Avg15.051yr Est28.33

AMLX News

4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year
zacks.com
4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year

Vertex Pharmaceuticals, Amylyx Pharmaceuticals, Praxis Precision Medicines and BridgeBio Pharma face

Amylyx Pharmaceuticals, Inc. $AMLX Shares Bought by Bank of New York Mellon Corp
defenseworld.net
Amylyx Pharmaceuticals, Inc. $AMLX Shares Bought by Bank of New York Mellon Corp

Bank of New York Mellon Corp raised its stake in Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) by 15.5

Amylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild
seekingalpha.com
Amylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild

Amylyx Pharmaceuticals (AMLX) is transitioning from its ALS legacy to a late-stage endocrine company

Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2026 Earnings Call Transcript
seekingalpha.com
Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2026 Earnings Call Transcript

Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2026 Earnings Call Transcript

Amylyx Pharmaceuticals Q2 Earnings Call Highlights
marketbeat.com
Amylyx Pharmaceuticals Q2 Earnings Call Highlights

Amylyx Pharmaceuticals NASDAQ: AMLX said its pivotal Phase III LUCIDITY trial of avexitide in post-b

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results
businesswire.com
Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Reports Second Quarter 2026 Fina

Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
businesswire.com
Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Report Second Quarter 2026 Fi

Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob

Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026
businesswire.com
Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Present Data from First-in-Hu

Amylyx Pharmaceuticals Eyes Q3 Phase 3 Avexitide Readout as PBH Launch Plans Take Shape
marketbeat.com
Amylyx Pharmaceuticals Eyes Q3 Phase 3 Avexitide Readout as PBH Launch Plans Take Shape

Amylyx Pharmaceuticals NASDAQ: AMLX Co-Chief Executive Officer Justin Klee said the company is prepa

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com
Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen

Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026
gurufocus.com
Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026

[url="]Amylyx Pharmaceuticals, Inc.[/url] (NASDAQ: AMLX) (“Amylyx” or the “Company”) today a

Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026
businesswire.com
Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Announces Poster Presentations a

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Securities of Amylyx Pharmaceuticals, Inc. – AMLX
globenewswire.com
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Securities of Am

BOSTON, June 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the United States District Co

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation
businesswire.com
Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data f

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Com

Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus
marketbeat.com
Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus

Amylyx Pharmaceuticals NASDAQ: AMLX is preparing for a pivotal Phase 3 readout for AVEXITIDE, its le

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
seekingalpha.com
Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Bank of America Global Healthcare Conference 2026 Tr

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Bank of America Global Healthcare Conference 2026 Tr

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2026 Earnings Call Transcript
seekingalpha.com
Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2026 Earnings Call Transcript

Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2026 Earnings Call Transcript

Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results
businesswire.com
Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Reports First Quarter 2026 Finan

Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia
businesswire.com
Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypogly

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Com

Amylyx Pharmaceuticals Sets Up Q3 Phase 3 Avexitide Data Readout, Eyes Potential 2027 Launch
defenseworld.net
Amylyx Pharmaceuticals Sets Up Q3 Phase 3 Avexitide Data Readout, Eyes Potential 2027 Launch

Amylyx Pharmaceuticals (NASDAQ: AMLX) is entering what it described as a pivotal year for its lead p

Beyond Meat Posts Downbeat Q4 Results, Joins RH, ORIC Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Beyond Meat Posts Downbeat Q4 Results, Joins RH, ORIC Pharmaceuticals And Other Big Stocks Moving Lo

US stock futures higher with Dow up 200 pts, Beyond Meat shares drop after downbeat results; ORIC, R

Earnings Scheduled For March 3, 2026
benzinga.com
Earnings Scheduled For March 3, 2026

Earnings Scheduled For November 6, 2025
benzinga.com
Earnings Scheduled For November 6, 2025

benzinga.com
Earnings Scheduled For August 7, 2025

benzinga.com
Earnings Scheduled For May 8, 2025

benzinga.com
Earnings Scheduled For March 4, 2025

benzinga.com
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the co

benzinga.com
Earnings Scheduled For February 22, 2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings

benzinga.com
Earnings Scheduled For November 9, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 647 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday's session, 275 companies made new 52-week lows.

benzinga.com
Earnings Scheduled For August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023

benzinga.com
Earnings Scheduled For May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023

benzinga.com
Earnings Scheduled For November 10, 2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings

benzinga.com
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday

Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The compan

benzinga.com
82 Biggest Movers From Yesterday

Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tu

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 1043 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 849 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 431 companies hit new 52-week lows.

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022

Upgrades

benzinga.com
Stocks That Hit 52-Week Lows On Monday

    On Monday, 147 stocks hit new 52-week lows.

benzinga.com
80 Biggest Movers From Yesterday

Gainers  

benzinga.com
48 Biggest Movers From Yesterday

Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday